Assessing efficacy in early-phase cancer prevention trials: the case of oral premalignancy.
作者信息
Szabo Eva
机构信息
Lung and Upper Aerodigestive Cancer Research Group, Division of Cancer Prevention, National Cancer Institute, NIH, Department of Health and Human Services, Bethesda, MD 20892, USA.
出版信息
Cancer Prev Res (Phila). 2008 Oct;1(5):312-5. doi: 10.1158/1940-6207.CAPR-08-0171.
Abstract
摘要
Zotero 插件